These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7354471)

  • 1. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of drugs on serum histidine levels in rheumatoid arthritis.
    Dixon JS; Sitton NG; Surrall KE; Martin MF; Pickup ME; Bird HA
    Rheumatol Int; 1983; 3(4):145-9. PubMed ID: 6366988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the usefulness of delayed-action preparations in the treatment of rheumatoid polyarthritis by analyzing the therapeutic maintenance dose].
    Dougados M; Nguyen M; Duchesne L; Benjelloun M; Amor B
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):89-92. PubMed ID: 2727586
    [No Abstract]   [Full Text] [Related]  

  • 4. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial.
    Brewer EJ; Giannini EH; Kuzmina N; Alekseev L
    N Engl J Med; 1986 May; 314(20):1269-76. PubMed ID: 3517643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some rheological properties of blood during anti-rheumatoid therapy.
    Bird HA; Harkness J; Wright V
    Pharmatherapeutica; 1981; 3(1):36-9. PubMed ID: 7323107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and clinical changes occurring during the treatment of rheumatoid arthritis with novel antirheumatoid drugs.
    Dixon JS; Bird HA; Martin MF; McKenna F; Wright V
    Int J Clin Pharmacol Res; 1985; 5(1):25-33. PubMed ID: 2860075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
    Pincus T; Marcum SB; Callahan LF
    J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy.
    Ferraccioli G; Falleti E; De Vita S; Di Poi E; Damato R; Casatta L; Salaffi F
    J Rheumatol; 1998 Oct; 25(10):1874-9. PubMed ID: 9779838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillamine in rheumatoid arthritis. Connective tissue changes and alterations in serum copper and phase reactants in relation to clinical improvement.
    Hansen TM; Manthorpe R; Kofod B; Andreassen T; Oxlund H; Lorenzen IB
    J Rheumatol; 1976 Dec; 3(4):367-74. PubMed ID: 1022870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs].
    Jiang L; Zhao N; Ni L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Jun; 23(3):213-7. PubMed ID: 12411093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis.
    Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M
    Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
    Dixon JS; Greenwood M; Bird HA
    Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete reversal of rheumatoid nodulosis.
    McCarty DJ
    J Rheumatol; 1991 May; 18(5):736-7. PubMed ID: 1865421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
    Husain Z; Runge LA
    J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.